Differential Pharmacological Activities of Oxygen Numbers on the Sulfoxide Moiety of Wasabi Compound 6-(Methylsulfinyl) Hexyl Isothiocyanate in Human Oral Cancer Cells

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2018 Sep 26

PMID 30248933

Citations 7

Authors

Min-Ju Lee

Wen-Ser Tseng

Jerry Cheng-Yen Lai

Hui-Ru Shieh

Chih-Wen Chi

Yu-Jen Chen

Affiliations

Soon will be listed here.

Abstract

6-(methylsulfinyl) hexyl isothiocyanate (6-MITC) is a naturally occurring compound isolated from (wasabi). The synthetic derivatives, 6-(methylsulfenyl) hexyl isothiocyanate (I7447) and 6-(methylsulfonyl) hexyl isothiocyanate (I7557), were derived from 6-MITC with the deletion and addition of oxygen, respectively. We aimed to evaluate the effect of these synthetic compounds on human oral cancer cells, SAS and OECM-1. All three compounds (I7447, 6-MITC, and I7557) inhibited the viability of SAS and OECM-1 cells using MTT assay. Morphological observations showed various proportions of mitotic arrest and apoptosis in cells treated with these compounds. Cell cycle analysis revealed relatively abundant G2/M arrest in 6-MITC and I7557-treated cells, whereas sub-G1 accumulation was found in I7447-treated cells. In using phosphorylated histone H3 as a marker for mitosis, the addition of 6-MITC and I7557 (excluding I7447) could be shown to arrest cells during mitosis. In contrast, I7447 induced more prominent apoptosis than the 6-MITC or I7557 compounds. The down-regulated expression of the phosphorylated form of CHK1 and Cdc25c was noted in 6-MITC and I7557-treated cells. I7557 could sensitize SAS cells to death by radiation. The wasabi compound, 6-MITC, and its chemical derivatives with different numbers of oxygen may have differential pharmacological effects on human oral cancer cells.

Citing Articles

Advances in Small Molecular Agents against Oral Cancer.

Wei K, Zhu W, Kou Y, Zheng X, Zheng Y Molecules. 2024; 29(7).

PMID: 38611874 PMC: 11013889. DOI: 10.3390/molecules29071594.

Anti-Cancer Effects of Oxygen-Atom-Modified Derivatives of Wasabi Components on Human Leukemia Cells.

Lin J, Chi C, Huang Y, Tsai T, Chen Y Int J Mol Sci. 2023; 24(7).

PMID: 37047794 PMC: 10095376. DOI: 10.3390/ijms24076823.

Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells.

Ono M, Miyamoto T, Fuseya C, Asaka R, Ando H, Tanaka Y Discov Oncol. 2023; 14(1):9.

PMID: 36689027 PMC: 9871149. DOI: 10.1007/s12672-023-00617-2.

6-(Methylsulfonyl) Hexyl Isothiocyanate: A Chemopreventive Agent Inducing Autophagy in Leukemia Cell Lines.

Cocchi V, Javega B, Gasperini S, OConnor J, Lenzi M, Hrelia P Biomolecules. 2022; 12(10).

PMID: 36291694 PMC: 9599183. DOI: 10.3390/biom12101485.

Wasabi Component 6-(Methylsulfinyl)hexly Isothiocyanate and Derivatives Improve the Survival of Skin Allografts.

Huang T, Ko C, Lin J, Hsu M, Ko C, Chi C Int J Mol Sci. 2022; 23(15).

PMID: 35955623 PMC: 9369098. DOI: 10.3390/ijms23158488.

References

Yano S, Wu S, Sakao K, Hou D . Wasabi 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human colorectal cancer cells through p53-independent mitochondrial dysfunction pathway. Biofactors. 2018; . DOI: 10.1002/biof.1431. View

Strunz A, Peschke P, Waldeck W, Ehemann V, Kissel M, Debus J . Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control. Int J Radiat Biol. 2002; 78(8):721-32. DOI: 10.1080/09553000210141667. View

Morroni F, Sita G, Tarozzi A, Cantelli-Forti G, Hrelia P . Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease. Brain Res. 2014; 1589:93-104. DOI: 10.1016/j.brainres.2014.09.033. View

Yamaguchi H, Kidachi Y, Kamiie K, Noshita T, Umetsu H, Fuke Y . Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies. Biochem Pharmacol. 2013; 86(4):458-68. DOI: 10.1016/j.bcp.2013.06.008. View

Meleti M, Leemans C, Mooi W, Vescovi P, van der Waal I . Oral malignant melanoma: a review of the literature. Oral Oncol. 2006; 43(2):116-21. DOI: 10.1016/j.oraloncology.2006.04.001. View

Liu C, Chang H, Chen I, Chen C, Hsu M, Fu S . Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells. Radiat Oncol. 2011; 6:56. PMC: 3123574. DOI: 10.1186/1748-717X-6-56. View

Fuke Y, Shinoda S, Nagata I, Sawaki S, Murata M, Ryoyama K . Preventive effect of oral administration of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum) against pulmonary metastasis of B16-BL6 mouse melanoma cells. Cancer Detect Prev. 2006; 30(2):174-9. DOI: 10.1016/j.cdp.2005.10.005. View

Wardman P . Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol). 2007; 19(6):397-417. DOI: 10.1016/j.clon.2007.03.010. View

Basu T, Laskar S, Gupta T, Budrukkar A, Murthy V, Agarwal J . Toxicity with radiotherapy for oral cancers and its management: a practical approach. J Cancer Res Ther. 2012; 8 Suppl 1:S72-84. DOI: 10.4103/0973-1482.92219. View

10.

Fuke Y, Hishinuma M, Namikawa M, Oishi Y, Matsuzaki T . Wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human breast cancer by possible involvement of the NF-κB pathways. Nutr Cancer. 2014; 66(5):879-87. DOI: 10.1080/01635581.2014.916322. View

11.

Vazquez-Mahia I, Seoane J, Varela-Centelles P, Tomas I, Alvarez Garcia A, Lopez Cedrun J . Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg. 2011; 70(7):1724-32. DOI: 10.1016/j.joms.2011.06.228. View

12.

Yu C, Hung S, Liao H, Lee C, Lin H, Lai H . RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint. Anticancer Res. 2014; 34(6):2927-35. View

13.

Wu Y, Wu W, Lin L, Liu C, Ho S, Wang B . Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation. J Exp Clin Cancer Res. 2018; 37(1):91. PMC: 5921410. DOI: 10.1186/s13046-018-0760-0. View

14.

Mitsiogianni M, Amery T, Franco R, Zoumpourlis V, Pappa A, Panayiotidis M . From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention. Pharmacol Ther. 2018; 190:187-201. DOI: 10.1016/j.pharmthera.2018.06.001. View

15.

Lenzi M, Cocchi V, Malaguti M, Barbalace M, Marchionni S, Hrelia S . 6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines. Oncotarget. 2018; 8(67):111697-111714. PMC: 5762353. DOI: 10.18632/oncotarget.22902. View

16.

Chen Y, Huang Y, Tsai T, Liao H . Effect of Wasabi Component 6-(Methylsulfinyl)hexyl Isothiocyanate and Derivatives on Human Pancreatic Cancer Cells. Evid Based Complement Alternat Med. 2014; 2014:494739. PMC: 3918374. DOI: 10.1155/2014/494739. View

17.

Nomura T, Shinoda S, Yamori T, Sawaki S, Nagata I, Ryoyama K . Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro. Cancer Detect Prev. 2005; 29(2):155-60. DOI: 10.1016/j.cdp.2004.07.010. View

18.

Noguti J, DE Moura C, Protasio Pacheco de Jesus G, da Silva V, Hossaka T, Oshima C . Metastasis from oral cancer: an overview. Cancer Genomics Proteomics. 2012; 9(5):329-35. View

19.

Chiang I, Liu Y, Hsu F, Chien Y, Kao C, Lin W . Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity. Oncol Rep. 2014; 31(4):1729-37. DOI: 10.3892/or.2014.3009. View

20.

Shield K, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi A, Bray F . The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017; 67(1):51-64. DOI: 10.3322/caac.21384. View